WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS

Concenter BioPharma chosen as WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS

Category: Best Specialty Drug Platform - ISRAEL


https://www.ghp-news.com/winners/concenter-biopharma-ltd/

https://www.ghp-news.com/ghp-magazine-announces-the-winners-of-the-2021-biotechnology-awards/


April 2021 press release:

United Kingdom, 2021– GHP Magazine has announced the winners of the 2021 Biotechnology Awards.

As ever, the field of Biotechnology continues to innovate and impress on the greater landscape. In the midst of the COVID-19 pandemic, we saw exceptional scientific advances that would otherwise have been considered close to impossible to achieve. The Biotechnology’s experts certainly had a hand to play in these advances, and as such, played a critical role. That shouldn’t be overlooked. It is with this in mind that we hosted the 2021 edition of the programme.

GHP, as always, endeavour to recognise those that are going above and beyond, or indeed, the businesses that are making meaningful steps forward, no matter how small they might seem on the greater landscape. That’s why we launched the Biotechnology programme, and why we continue to spotlight the work of exceptional companies and individuals.

Awards Co-ordinator Kaven Cooper took a moment to comment on the awards and their deserving winners: “It has been a challenging past 12 months for all those in medical and scientific fields. However, it has been a delight to recognise people from all over the world for their contributions to the science community. Congratulations to all, and I hope you all have a fantastic 2021 ahead.”

To find out more about these leading lights and discover what has led them to becoming who they are today, please visit http://www.ghp-news.com/ to access our winners supplement.


Stop Diabetes, Pills and Sugar Cubes
Stop Diabetes

Logo concenter biopharma.jpg

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications. 

 

Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Let the news
come to you.

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter